Jan 31, 2023
Tuvik Beker, CEO of Pangea Biomed, is looking for more accurate biomarkers for oncology to determine better who might benefit from a specific drug. Their ENLIGHT platform is a pan-cancer, pan-treatment response predictor and can be used to find the best patient populations to give a new drug. They are also working with...
Jan 31, 2023
Tuvik Beker CEO of Pangea Biomed is looking for more accurate biomarkers for oncology to better determine who might benefit from a specific drug. Their ENLIGHT platform is a pan-cancer, pan-treatment response predictor and can be used to find the best patient populations to give a new drug. They are also working with...
Precision Medicine Requires More Accessible and Affordable Advanced Diagnostics with Mehdi Maghsoodnia 1health TRANSCRIPT
Download PDFJan 23, 2023
Mehdi Maghsoodnia is the CEO of 1health and is determined to bring advanced diagnostic medical tests to a broader audience to enable more patients to benefit from precision medicine advancements. Too often, patients are put on costly drugs that are not effective. Using data from advanced testing allows clinicians to...
Jan 23, 2023
Mehdi Maghsoodnia is the CEO of 1health and is determined to bring advanced diagnostic medical tests to a broader audience to enable more patients to benefit from precision medicine advancements. Too often, patients are put on costly drugs that are not effective. Using data from advanced testing allows clinicians to...
Multiplexed Diagnostic Test for Detecting Levels of Multiple Antibodies with Dr. Tadd Lazarus Pictor TRANSCRIPT
Download PDFJan 10, 2023
Dr. Tadd Lazarus is the Chief Medical Officer at Pictor, working on innovative diagnostic tests to provide answers to complicated clinical questions concerning the status of a patient's level of antibodies. From one specimen, their test can determine if the antibodies have been produced as a result of vaccinations or...